# NNVC (Nanoviricides, Inc.) - SEC EDGAR Financial Statements

> Nanoviricides, Inc. reported $0 in revenue and a net loss of $12.18M for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/NNVC
- Markdown: https://convexityos.com/fundamentals/NNVC.md
- SEC CIK: 0001379006
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001379006&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$12.28M | Operating profit |
| Net Income | TTM | -$12.18M | GAAP bottom line |
| Diluted EPS | TTM | -$0.49 | Split-adjusted |
| Free Cash Flow | TTM | -$7.78M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $2.58M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Research & Development | $4.71M | $5.55M | $5.44M | $6.39M | $5.78M | $6.11M | $4.70M | $5.92M | $5.91M | $6.57M |
| Total Operating Expenses | $8.31M | $9.59M | $8.52M | $8.94M | $8.11M | $8.74M | $8.00M | $8.66M | $9.33M | $9.60M |
| **Operating Income** | -$8.31M | -$9.59M | -$8.52M | -$8.94M | -$8.11M | -$8.74M | -$8.00M | -$8.66M | -$9.33M | -$9.60M |
| **EBITDA** | -$7.78M | -$8.85M | -$7.76M | -$8.20M | -$7.39M | -$8.04M | -$7.30M | -$7.96M | -$8.65M | -$8.94M |
| Interest Expense | -- | $149 | $50K | $938 | $5.1K | $85K | $94K | $0 | $185K | $781K |
| Income Before Tax | -$8.22M | -- | -- | -- | -$8.11M | -$8.82M | -$13.45M | -$8.42M | -$8.56M | -$10.30M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| **Net Income** | -$8.22M | -$9.47M | -$8.29M | -$8.59M | -$8.11M | -$8.82M | -$13.45M | -$8.42M | -$8.56M | -$10.30M |
| Basic EPS | -$0.41 | -$0.63 | -$0.70 | -$0.74 | -$0.70 | -$0.81 | -$2.39 | -$2.35 | -$0.01 | -$0.01 |
| **Diluted EPS** | -$0.41 | -$0.63 | -$0.70 | -$0.74 | -$0.70 | -$0.81 | -$2.39 | -$2.35 | -$0.01 | -$0.01 |
| Basic Shares Outstanding | 20.2M | 15.1M | 11.9M | 11.6M | 11.5M | 10.9M | 5.6M | 3.6M | 1.30B | 1.20B |
| Diluted Shares Outstanding | 20.2M | 15.1M | 11.9M | 11.6M | 11.5M | 10.9M | 5.6M | 3.6M | 1.30B | 1.20B |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $4.70M | $1.31M | $1.29M | $1.12M | $993K | $1.18M | $1.28M | $1.16M |
| Total Operating Expenses | $5.77M | $2.25M | $2.03M | $2.23M | $1.80M | $2.12M | $2.25M | $2.06M |
| **Operating Income** | -$5.77M | -$2.25M | -$2.03M | -$2.23M | -$1.80M | -$2.12M | -$2.25M | -$2.06M |
| **EBITDA** | -$5.64M | -$2.12M | -$1.90M | -$2.10M | -$1.66M | -$1.95M | -$2.06M | -$1.86M |
| Interest Income | $26K | -- | -- | -- | $12K | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $149 |
| **Net Income** | -$5.74M | -$2.22M | -$1.99M | -$2.22M | -$1.79M | -$2.10M | -$2.22M | -$2.03M |
| Basic EPS | -$0.23 | -- | -$0.09 | -$0.11 | -$0.10 | -- | -$0.14 | -$0.14 |
| **Diluted EPS** | -$0.23 | -- | -$0.09 | -$0.11 | -$0.10 | -- | -$0.14 | -$0.14 |
| Basic Shares Outstanding | 24.8M | -- | 21.6M | 19.9M | 17.1M | -- | 16.0M | 14.6M |
| Diluted Shares Outstanding | 24.8M | -- | 21.6M | 19.9M | 17.1M | -- | 16.0M | 14.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.79M | $1.56M | $4.80M | $8.15M | $14.07M | $20.52M | $13.71M | $2.56M | $7.08M | $15.10M |
| **Cash & Short-Term Investments** | $2.79M | $1.56M | $4.80M | $8.15M | $14.07M | $20.52M | $13.71M | $2.56M | $7.08M | $15.10M |
| **Total Current Assets** | $3.16M | $1.67M | $4.97M | $8.45M | $14.42M | $20.82M | $13.99M | $2.83M | $7.32M | $15.29M |
| Property, Plant & Equipment, Net | $6.40M | $6.83M | $7.51M | $8.11M | $8.69M | $9.08M | $9.54M | $10.23M | $10.84M | $11.27M |
| Intangible Assets | $309K | $317K | $325K | $334K | $342K | $350K | $358K | $367K | $375K | $383K |
| **Total Non-Current Assets** | $6.71M | $7.15M | $7.85M | $8.45M | $9.08M | $9.44M | $9.93M | $10.62M | $11.22M | $11.71M |
| **Total Assets** | $9.87M | $8.82M | $12.82M | $16.90M | $23.49M | $30.26M | $23.91M | $13.45M | $18.55M | $27.00M |
| Accounts Payable | -- | -- | -- | -- | $58K | $200K | $381K | $310K | $223K | $136K |
| **Total Current Liabilities** | $1.19M | $1.31M | $1.36M | $534K | $413K | $351K | $2.16M | $2.85M | $882K | $4.67M |
| **Total Non-Current Liabilities** | $9.3K | -$6.5K | $0 | $1.50M | $0 | $0 | $0 | $0 | $0 | $2.02M |
| **Total Liabilities** | $1.20M | $1.30M | $1.36M | $2.03M | $413K | $351K | $2.16M | $2.85M | $882K | $6.68M |
| Common Stock | $230 | $166 | $131 | $117 | $116 | $12K | $9.1K | $3.8K | $69K | $63K |
| Retained Earnings | -$157.1M | -$148.8M | -$139.4M | -$131.1M | -$122.5M | -$114.4M | -$105.6M | -$92.12M | -$83.69M | -$75.13M |
| **Total Stockholders' Equity** | $8.68M | $7.52M | $11.46M | $14.87M | $23.08M | $29.91M | $21.76M | $10.60M | $17.66M | $20.32M |
| Total Equity | $8.68M | $7.52M | $11.46M | $14.87M | $23.08M | $29.91M | $21.76M | $10.60M | $17.66M | $20.32M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.58M | $2.79M | $3.21M | $5.15M | $1.13M | $1.56M | $2.54M | $3.96M |
| **Cash & Short-Term Investments** | $2.58M | $2.79M | $3.21M | $5.15M | $1.13M | $1.56M | $2.54M | $3.96M |
| **Total Current Assets** | $2.98M | $3.16M | $3.38M | $5.30M | $1.25M | $1.67M | $2.73M | $4.07M |
| Property, Plant & Equipment, Net | $6.28M | $6.40M | $6.53M | $6.66M | $6.79M | $6.83M | $6.98M | $7.17M |
| Intangible Assets | $307K | $309K | $311K | $313K | $315K | $317K | $319K | $321K |
| **Total Non-Current Assets** | $6.58M | $6.71M | $6.84M | $6.97M | $7.10M | $7.15M | $7.30M | $7.50M |
| **Total Assets** | $9.56M | $9.87M | $10.22M | $12.27M | $8.36M | $8.82M | $10.03M | $11.57M |
| **Total Current Liabilities** | $3.15M | $1.19M | $1.07M | $1.20M | $1.18M | $1.31M | $1.20M | $1.18M |
| **Total Non-Current Liabilities** | $50K | $9.3K | $35K | $4.1K | $18K | -$6.5K | $0 | $16K |
| **Total Liabilities** | $3.20M | $1.20M | $1.10M | $1.20M | $1.20M | $1.30M | $1.20M | $1.20M |
| Common Stock | $255 | $230 | $216 | $216 | $176 | $166 | $160 | $156 |
| Retained Earnings | -$162.8M | -$157.1M | -$154.8M | -$152.8M | -$150.6M | -$148.8M | -$146.7M | -$144.5M |
| **Total Stockholders' Equity** | $6.41M | $8.68M | $9.15M | $11.07M | $7.17M | $7.52M | $8.83M | $10.39M |
| Total Equity | $6.41M | $8.68M | $9.15M | $11.07M | $7.17M | $7.52M | $8.83M | $10.39M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.22M | -$9.47M | -$8.29M | -$8.59M | -$8.11M | -$8.82M | -$13.45M | -$8.42M | -$8.56M | -$10.30M |
| Depreciation & Amortization | $525K | $744K | $759K | $748K | $723K | $705K | $700K | $696K | $680K | $663K |
| Stock-Based Compensation | -- | -- | $563 | $44K | -- | $0 | $0 | $36K | $156K | -- |
| Change in Payables | -$135K | $83K | $219K | $99K | -$142K | -$181K | $123K | $87K | $88K | $39K |
| **Operating Cash Flow** | -$7.70M | -$8.48M | -$6.32M | -$5.67M | -$5.89M | -$8.21M | -$6.67M | -$6.80M | -$7.78M | -$7.90M |
| Capital Expenditure | -$84K | -$57K | -$157K | -$152K | -$324K | -$239K | -$8.6K | -$74K | -$242K | -$165K |
| **Free Cash Flow** | -$7.78M | -$8.54M | -$6.47M | -$5.82M | -$6.22M | -$8.45M | -$6.67M | -$6.88M | -$8.02M | -$8.06M |
| **Investing Cash Flow** | -$84K | -$57K | -$157K | -$152K | -$324K | -- | -- | -- | -- | -$165K |
| Common Stock Issued | $1.91M | $5.30M | $117K | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $9.02M | $5.30M | $3.12M | -$95K | -$235K | $15.26M | $17.83M | $2.35M | $0 | -$1.00M |
| **Net Change in Cash** | $1.24M | -$3.24M | -$3.35M | -$5.92M | -$6.45M | $6.81M | $11.15M | -$4.53M | -$8.02M | -$9.06M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.74M | -$2.22M | -$1.99M | -$2.22M | -$1.79M | -$2.10M | -$2.22M | -$2.03M |
| Depreciation & Amortization | $128K | $130K | $130K | $133K | $133K | $161K | $191K | $196K |
| Change in Payables | $204K | -- | -- | -- | -$57K | -- | -- | -$461K |
| **Operating Cash Flow** | -$3.64M | -$2.12M | -$1.93M | -$2.05M | -$1.59M | -$1.70M | -$1.99M | -$2.19M |
| Capital Expenditure | -- | -$1 | $0 | $1 | -$84K | -$10K | $0 | $0 |
| **Free Cash Flow** | -- | -$2.12M | -$1.93M | -$2.05M | -$1.68M | -$1.71M | -$1.99M | -$2.19M |
| **Investing Cash Flow** | -- | -$1 | $0 | $1 | -$84K | -$10K | $0 | $0 |
| Common Stock Issued | -- | -- | -- | $22K | $44K | -- | $103K | $103K |
| **Financing Cash Flow** | $3.42M | $1.70M | -$6.7K | $6.07M | $1.25M | $728K | $576K | $2.28M |
| **Net Change in Cash** | -$219K | -$419K | -$1.94M | $4.02M | -$433K | -$984K | -$1.42M | $92K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -94.7% | -125.9% | -72.3% | -57.8% | -35.1% | -29.5% | -61.8% | -79.5% | -48.5% | -50.7% |
| Return on Assets (ROA) | -83.2% | -107.3% | -64.7% | -50.8% | -34.5% | -29.2% | -56.2% | -62.6% | -46.2% | -38.2% |
| Current Ratio | 2.66x | 1.28x | 3.66x | 15.81x | 34.92x | 59.30x | 6.49x | 0.99x | 8.30x | 3.28x |
| Quick Ratio | 2.35x | 1.19x | 3.53x | 15.25x | 34.07x | 58.43x | 6.36x | 0.90x | 8.03x | 3.24x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -189.9% | -94.7% | -88.4% | -75.1% | -113.2% | -125.9% | -110.1% | -90.2% |
| Return on Assets (ROA) | -127.3% | -83.2% | -79.2% | -67.8% | -97.2% | -107.3% | -97.0% | -80.9% |
| Current Ratio | 0.95x | 2.66x | 3.17x | 4.43x | 1.06x | 1.28x | 2.27x | 3.44x |
| Quick Ratio | 0.82x | 2.35x | 3.02x | 4.31x | 0.95x | 1.19x | 2.12x | 3.34x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
